Aytu Biopharma
Aytu Biopharma is a specialty pharmaceutical company focused on developing and commercializing products for various healthcare conditions. The company primarily targets urological indications, with an emphasis on male sexual dysfunction and male infertility, while exploring opportunities in other related areas. In addition to its urological focus, Aytu Biopharma offers prescription therapeutics for attention deficit hyperactivity disorder and other common pediatric conditions. The company is also advancing a therapeutic pipeline that includes AR101/enzastaurin, a prospective treatment for vascular Ehlers-Danlos Syndrome, a rare genetic disorder characterized by serious health complications. This treatment has received Orphan Drug designation from the FDA, highlighting its potential importance in addressing unmet medical needs. Aytu Biopharma’s diverse portfolio reflects its commitment to improving patient outcomes across various therapeutic areas.
Neos Therapeutics
Acquisition in 2020
Neos Therapeutics, Inc. is a pharmaceutical company focused on the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its specialized drug delivery technology. The company's product lineup includes extended-release medications such as Adzenys XR-ODT and Cotempla XR-ODT, both designed for ADHD treatment, along with Adzenys ER and a generic version of Tussionex, which is used for cough relief. Neos also has a clinical-stage product candidate, NT0502, aimed at treating neurological conditions associated with excessive salivation. Established in 2009 and headquartered in Grand Prairie, Texas, Neos Therapeutics operates a state-of-the-art manufacturing facility and emphasizes high-quality products to meet critical medical needs in the United States.
Innovus Pharmaceuticals
Acquisition in 2019
Innovus Pharmaceuticals is a San Diego-based pharmaceutical company founded in 2011 that focuses on developing, in-licensing, acquiring, and marketing both prescription and consumer health products. The company specializes in areas such as dermatology, autoimmune disorders, respiratory diseases, and sexual dysfunction, aiming to enhance patient compliance and outcomes through innovative packaging and presentation. Innovus Pharma is committed to the commercialization and licensing of safe, effective non-prescription medications and consumer care products that address the health and vitality of both men and women. Its distribution strategy includes working with commercial partners to reach primary care physicians, urologists, gynecologists, and therapists, as well as selling products directly to consumers.
Nuelle
Acquisition in 2017
Nuelle is a sexual wellness and intimate care company focused on delivering groundbreaking solutions made specifically for women. It marries its experience in healthcare solutions, consumer products, and technology with a deep understanding of women’s unfulfilled needs. From inception, Nuelle has taken a holistic view of these needs and desires. They worked closely with thought leaders and experts in women’s sexual medicine and wellness including physicians, sex therapists, physical therapists, and psychologists. Together we developed insights that allow Nuelle to translate its scientific approach to understanding.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.